NO864382D0 - Midler for forbedring av proteinabsorpsjon. - Google Patents

Midler for forbedring av proteinabsorpsjon.

Info

Publication number: NO864382D0
Authority: NO; Norway
Prior art keywords: measures; improving protein; protein absorption; absorption; improving
Prior art date: 1985-03-06

Application number

NO864382A

Other languages

English (en)

Norwegian (no)

Other versions

NO864382L (no

Inventor

Stanley Jay Sarnoff

Burton E Sobel

Original Assignee

Survival Technology

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1985-03-06

Filing date

1986-11-03

Publication date

1986-11-03

1985-03-06 Priority claimed from US06/708,845 external-priority patent/US4661469A/en

1985-10-01 Priority claimed from US06/782,441 external-priority patent/US4772585A/en

1986-03-11 Publication of NO864382L publication Critical patent/NO864382L/no

1986-11-03 Application filed by Survival Technology filed Critical Survival Technology

1986-11-03 Publication of NO864382D0 publication Critical patent/NO864382D0/no

Links

238000010521 absorption reaction Methods 0.000 title abstract 3
102000004169 proteins and genes Human genes 0.000 title abstract 3
108090000623 proteins and genes Proteins 0.000 title abstract 3
AVXURJPOCDRRFD-UHFFFAOYSA-N Hydroxylamine Chemical compound ON AVXURJPOCDRRFD-UHFFFAOYSA-N 0.000 abstract 1
239000008280 blood Substances 0.000 abstract 1
210000004369 blood Anatomy 0.000 abstract 1
230000002708 enhancing effect Effects 0.000 abstract 1
230000007721 medicinal effect Effects 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/38—Albumins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
- A61K38/49—Urokinase; Tissue plasminogen activator
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Engineering & Computer Science (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Immunology (AREA)
Bioinformatics & Cheminformatics (AREA)
Gastroenterology & Hepatology (AREA)
Oil, Petroleum & Natural Gas (AREA)
Biomedical Technology (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Dermatology (AREA)
Zoology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)

NO864382A 1985-03-06 1986-11-03 Midler for forbedring av proteinabsorpsjon. NO864382D0 (no)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
US06/708,845 US4661469A (en)	1984-08-08	1985-03-06	t-PA composition capable of being absorbed into the blood stream and method of administration
US71670585A	1985-03-27	1985-03-27
US06/782,441 US4772585A (en)	1984-08-08	1985-10-01	Protein thrombolytic agent with absorption enhancing agent
PCT/US1986/000475 WO1986005096A1 (en)	1985-03-06	1986-03-06	Protein absorption enhancing agents

Publications (2)

Publication Number	Publication Date
NO864382L NO864382L (no)	1986-03-11
NO864382D0 true NO864382D0 (no)	1986-11-03

Family

ID=27418848

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO864382A NO864382D0 (no)	1985-03-06	1986-11-03	Midler for forbedring av proteinabsorpsjon.

Country Status (9)

Country	Link
EP (1)	EP0214281B1 (da)
AT (1)	ATE80306T1 (da)
AU (1)	AU593794B2 (da)
DE (1)	DE3686684T2 (da)
DK (1)	DK528386A (da)
FI (1)	FI864480L (da)
HU (1)	HUT41632A (da)
NO (1)	NO864382D0 (da)
WO (1)	WO1986005096A1 (da)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4839170A (en) *	1985-10-01	1989-06-13	Survival Technology, Inc.	Protein absorption enhancing agents
DE3544663A1 (de) *	1985-12-13	1987-06-19	Schering Ag	Thrombosebehandlung mit fibrinolytika und prostacyclinen
DE3729863A1 (de) *	1987-09-05	1989-03-16	Boehringer Mannheim Gmbh	Stabilisierte erythropoietin-lyophilisate

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU596356B2 (en) *	1985-04-22	1990-05-03	Genentech Inc.	Novel human tissue plasminogen activator mutants
NO171344C (no) *	1985-05-28	1993-03-03	Wellcome Found	Fremgangsmaate for fremstilling av farmasoeytiske preparater inneholdende vevsplasminogenaktivator

1986
- 1986-03-06 WO PCT/US1986/000475 patent/WO1986005096A1/en not_active Ceased
- 1986-03-06 FI FI864480A patent/FI864480L/fi not_active Application Discontinuation
- 1986-03-06 EP EP86902132A patent/EP0214281B1/en not_active Expired - Lifetime
- 1986-03-06 HU HU863035A patent/HUT41632A/hu unknown
- 1986-03-06 DE DE8686902132T patent/DE3686684T2/de not_active Expired - Fee Related
- 1986-03-06 AU AU55811/86A patent/AU593794B2/en not_active Ceased
- 1986-03-06 AT AT86902132T patent/ATE80306T1/de not_active IP Right Cessation
- 1986-11-03 NO NO864382A patent/NO864382D0/no unknown
- 1986-11-05 DK DK528386A patent/DK528386A/da not_active Application Discontinuation

Also Published As

Publication number	Publication date
NO864382L (no)	1986-03-11
DE3686684D1 (de)	1992-10-15
EP0214281A4 (en)	1989-03-16
DE3686684T2 (de)	1993-01-28
AU593794B2 (en)	1990-02-22
AU5581186A (en)	1986-09-24
WO1986005096A1 (en)	1986-09-12
DK528386D0 (da)	1986-11-05
HUT41632A (en)	1987-05-28
EP0214281B1 (en)	1992-09-09
FI864480A7 (fi)	1986-11-04
FI864480A0 (fi)	1986-11-04
ATE80306T1 (de)	1992-09-15
EP0214281A1 (en)	1987-03-18
FI864480L (fi)	1986-11-04
DK528386A (da)	1986-11-05

Similar Documents

Publication	Publication Date	Title
DE3587941D1 (de)	1994-12-01	Gerät zur vorläufigen reperfusionsbehandlung von herzanfallsymptomen.
ATE77056T1 (de)	1992-06-15	Antikoerperkomplexe von haptenmodifizierten diagnostischen oder therapeutischen mitteln.
DE3687741D1 (de)	1993-03-25	Geraet zur ultraschallechographie der bewegung von koerperorganen, insbesondere der blutstroemung oder des herzens.
NO870241D0 (no)	1987-01-20	Hypoglykemiske tiazolidindioner.
DK614987A (da)	1987-11-23	Syntetiske htlv-iii peptider, praeparater og anvendelser deraf
JPS5231839A (en)	1977-03-10	Drug for cosmetics and permanent wave in combination
IT1067019B (it)	1985-03-12	Metodo e disposizione per misurare la concentrazione di composti di basso peso molecolare in mezzi complessi in particolare nel trattamento medicale
DK504389D0 (da)	1989-10-11	Adjuveret antigenoploesning, dens fremstilling samt zink- eller jernhydroxidgel til anvendelse derved
DK0416678T3 (da)	1993-12-20	Topiske præparater indeholdende Defibrotid
DE69523055D1 (de)	2001-11-08	T-zellen stimulierendes protein von pestivirus
DK528386D0 (da)	1986-11-05	Proteinabsorptionsforaegende midler
DK325289D0 (da)	1989-06-29	Strontiumsalt, fremgangsmaade til fremstilling heraf samt farmaceutiske midler indeholdende saltet
DE68928933D1 (de)	1999-04-01	Faser-hemagglutinin von b. pertussis
DE3688917D1 (de)	1993-09-30	Derivate eines Aminoketons.
FI92716C (fi)	1994-12-27	Uudet monoklonaaliset vasta-aineet IFN-omegalle, niiden valmistusmenetelmät ja niiden käyttö IFN-omegan puhdistamiseen ja osoittamiseen
FI844645L (fi)	1985-06-11	1,7-difenyl-3-metylaza-7-cyan-8 -metyl-nonan foer anvaendning vid bekaempning av sjukdomar.
IL76121A0 (en)	1985-12-31	Protein absorption enhancing agents
FI885025A0 (fi)	1988-11-01	Koagulationshaemmande protein pp4-x, dess framstaellning och anvaendning.
ATE79550T1 (de)	1992-09-15	Die proteinabsorption verbessernde stoffe.
ATE126437T1 (de)	1995-09-15	Verwendung von depogen zur behandlung von eingeschränktem blutkreislauf.
FI843695A7 (fi)	1985-03-24	Insuliini-johdannaisia, joissa B 30-asema on modifioitu, menetelmiä niiden valmistamiseksi ja niiden käyttö sekä sokeritaudin hoitoon tarkoitettuja lääkeaineita.
NO864742D0 (no)	1986-11-26	Dna-sekvens som koder for human vevsplasminogenaktivator, rekombinant dna-sekvens, vertcelle transformert med denne samt fremgangsmaate for fremstilling av plasminogenaktivatoren.
IT1178489B (it)	1987-09-09	Vettore clonante, procedimento per la sua costruzione e procedimento di concentrazione e di purificazione di proteine prodotte, formate dal vettore clonante
IT8621273A0 (it)	1986-07-25	Procedimento per la determinazione della concentrazione di immunoglobulina e in sieri umani.
ATE88359T1 (de)	1993-05-15	Aspirator zur aufnahme von koerperfluessigkeiten.